期刊文献+

糖尿病对心房颤动合并冠状动脉支架植入后患者预后的影响 被引量:3

Effect of diabetes on prognosis of patients with atrial fibrillation and coronary stent implantation
下载PDF
导出
摘要 目的探讨糖尿病对心房颤动(AF)合并冠状动脉支架植入后患者预后的影响。方法采用检索电子病历库方式,筛选出北京12家三级医院2010年1月至2015年1月收治的心房颤动合并急性冠脉综合征并行经皮冠状动脉介入治疗(PCI)的患者,采用电话或门诊方式对患者进行定期随访。收集符合入选标准患者2206例,平均随访时间为(3.33±1.46)年,排除失访患者,实际纳入患者1975例,进一步分组为糖尿病组(610例)和非糖尿病组(1365例)。对比分析两组患者基线资料、既往病史、临床检验检查等情况,随访截止至2016年3月。记录缺血性脑卒中、主要不良心血管事件(MACE)及出血事件发生情况。绘制不同终点事件的Kaplan-Meier生存曲线比较,并采用Log-rank法进行检验。结果糖尿病组缺血性脑卒中发生率7.0%、MACE发生率25.4%、全因死亡率14.5%,非糖尿病组缺血性脑卒中发生率4.8%、MACE发生率20.5%、全因死亡率10.1%,两组差异有统计学意义(P<0.05);糖尿病组出血事件发生率7.3%,非糖尿病出血事件发生率8.9%,两组差异无统计学意义(P>0.05)。结论合并糖尿病的心房颤动伴PCI后患者有更高的缺血性脑卒中风险及病死率;糖尿病不增加心房颤动合并PCI后患者出血事件发生风险。 Objective To investigate the effect of diabetes mellitus(DM)on the prognosis of patients with atrial fibrillation(AF)complicated with coronary artery stent implantation.Methods By retrieving electronic medical records,patients who had atrial fibrillation combined with acute coronary syndrome underwent Percutaneous Coronary Intervention(PCI)were screened from 12 tertiary hospitals in Beijing from January 2010 to January 2015,regular follow-up were carried out with patients by telephone or outpatient.2206 patients were recruited according to inclusion criteria,with an average follow-up time of(3.33 to 1.46)years.After excluding missing patients,and the actual inclusion number of patients was 1975 cases,who were further divided into diabetes group(610 cases)and non-diabetic group(1365 cases).Baseline data,past history,and clinical examination results were compared in two groups.Then GRACE score,CRUSADE score,CHA2DS2-VASc score,HAS-BLED score were performed according to the defined scoring criteria,and the follow-up end up on March 2016.Incidence of ischemic stroke,major adverse cardiovascular events(MACE),and bleeding were recorded in each patients.Kaplan-Meier survival curves for different endpoint events was plotted and then compared by the Log-rank method.Results In the diabetes group,incidence of ischemic stroke was 7.0%,incidence of MACE was 25.4%,all-cause mortality was 14.5%.In non-diabetic group,the incidence of ischemic stroke,incidence of MACE and all-cause mortality was 4.8%,20.5%and 10.1%,respectively.The differences between the two groups were statistically significant(P<0.05).The rate of bleeding events was 7.3%in the diabetic group and 8.9%in non-diabetic group.There was no statistically significant difference between the two groups(P>0.05).Conclusion The diabetic patients with atrial fibrillation and PCI surgery had a higher risk and mortality rate of ischemic stroke.Diabetes does not increase the risk of bleeding events in patients with atrial fibrillation and PCI surgery.
作者 李小龙 李田昌 Li Xiaolong;Li Tianchang(Sixth Medical Center of PLA General Hospital,Beijing 100048,China;不详)
出处 《中国循证心血管医学杂志》 2020年第5期572-575,共4页 Chinese Journal of Evidence-Based Cardiovascular Medicine
基金 首都临床特色应用研究与成果推广基金(Z151100004015205)。
关键词 糖尿病 心房颤动 冠状动脉支架植入术 缺血性脑卒中 Diabetes mellitus Atrial fibrillation Coronary artery stand interpolation Ischemic stroke
  • 相关文献

参考文献5

二级参考文献39

  • 1周自强,胡大一,陈捷,张仁汉,李奎宝,赵秀丽.中国心房颤动现状的流行病学研究[J].中华内科杂志,2004,43(7):491-494. 被引量:1398
  • 2胡大一,杨进刚.心房颤动的现代观点 (1)我国心房颤动流行概况和危害[J].中国循环杂志,2004,19(5):323-324. 被引量:40
  • 3胡大一,张鹤萍,孙艺红,姜立清.华法林与阿司匹林预防非瓣膜性心房颤动患者血栓栓塞的随机对照研究[J].中华心血管病杂志,2006,34(4):295-298. 被引量:162
  • 4白梅,杨杰孚.血浆脑钠肽与心房颤动[J].中华心律失常学杂志,2006,10(2):157-160. 被引量:17
  • 5Robert O. Bonow, Douglas L. Mann, Douglas P. Zipes. et al. Atrial Fibrillation. 《Braunwald心脏病学》.第9版.人民卫生出版社,2012.825.
  • 6Schmitt J, Duray G, Gersh BJ. et al. Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications, Eur Heart J, 2009, 30: 1038- 1045.
  • 7Kolh P, Windeeker S. ESC/EACTS myocardial revascularization guidelines 2014. Eur Heart J, 2014, 35: 3235-3236.
  • 8Fihn SD, Blaukenship JC, Smith PK. et al. 2014 ACC/AHA/AATS/ PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemie heart disease. J Am Coll Cardiol, 2014, 64: 1929-1949.
  • 9January CT, Wann LS, Yancy CW. et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation. Circulation, 2014, 130: e199-267.
  • 10Brignole M, Auricchio A, Wilson CM. et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynehronization therapy: the Task Force on cardiac pacing and resynehronization therapy of the European Society of Cardiology (ESC). Eur Heart J, 2013, 34: 2281-2329.

共引文献279

同被引文献44

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部